Advisory Committees

Direction and advice regarding CADTH optimal use projects are provided through:

• Canadian Drug Expert Committee (CDEC)
• Drug Policy Advisory Committee (DPAC)
• DPAC Optimal Use Working Group
• Health Technology Expert Review Panel (HTERP)

CADTH also develops expert review panels, as required, to support specific projects. Information on these panels is available on the web pages relating to the projects.

• Medical Isotopes and Imaging Modalities Advisory Committee (MIIMAC)
• CADTH MRI Expert Advisory Panel
• COMPUS Expert Review Panel on Proton Pump Inhibitors